Autoimmune lymphoproliferative syndrome (ALPS) is an inherited disease hindering apoptosis of lymphocytes. It includes mutations in genes coding for various components of the apoptotic pathway: CD95 (ALPS 0 and ALPS la), CD178 (ALPS Ib) and caspase-10 (ALPS II). Moreover, patients with genetically inherited caspase-8 or other components of apoptosis-inducing pathway deficiencies (ALPS III) have been described recently. In addition, ALPS-like clinical patterns, including Dianzani's autoimmune lymphoproliferative disease (DALD), were characterized. In this review, we summarize currently known types of ALPS and characterize their immunological and molecular background. © 2006 S. Karger GmbH.
CITATION STYLE
Brawura-Biskupski-Samaha, R., & Grzela, T. (2006, January). Autoimmune lymphoproliferative syndrome - Impaired regulation of the immune response by impaired induction of apoptosis. Transfusion Medicine and Hemotherapy. https://doi.org/10.1159/000090202
Mendeley helps you to discover research relevant for your work.